NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Hematology Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hematology Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Thrombolysis



Reports summarize thrombolysis study results from R. Meng and co-researchers



August 3rd, 2009

In this recently published article, scientists in Beijing, People's Republic of China conducted a study "To explore the value of dynamically monitored levels of plasma prothrombin fragment(1+2) (F1+2) and D-dimer in the process of thrombolysis with urokinase. Blood samples were collected at baseline and at hours 1, 2, 3, 6, 12, 24, 48, 72, and 96 after urokinase infusion finished."

"The levels of plasma F1+2 and D-dimer of 45 patients who received urokinase intravenous infusion were assayed by ELISA and fluorescent immunoassay, and analysed dynamically with their clinical outcomes. The levels of plasma F1+2 and D-dimer in patients before urokinase thrombolysis were...


Source: Hematology Week (2009-08-03)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login